{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:21:03Z","timestamp":1760217663631,"version":"3.44.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.annder.2014.11.011","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T12:16:35Z","timestamp":1419855395000},"page":"115-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Scl\u00e9rose cutan\u00e9e des deux membres inf\u00e9rieurs sous pemetrexed"],"prefix":"10.1016","volume":"142","author":[{"given":"C.","family":"Corbaux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Marie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-P.","family":"Meraud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-Y.","family":"Delhoume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Jouary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Madoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2014.11.011_bib0005","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1158\/1078-0432.982.11.3","article-title":"Pemetrexed in malignant pleural mesothelioma","volume":"11","author":"Hazarika","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.annder.2014.11.011_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2010.12.021","article-title":"Pemetrexed rechallenge in pleural malignant mesothelioma: an option for a subset of patients initially treated with pemetrexed-platinum doublets in the first-line setting?","volume":"72","author":"Zalcman","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.annder.2014.11.011_bib0015","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1517\/14728210903074563","article-title":"Malignant pleural mesothelioma: current treatments and emerging drugs","volume":"14","author":"Belli","year":"2009","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.annder.2014.11.011_bib0020","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1634\/theoncologist.2010-0224","article-title":"Approval summary: pemetrexed maintenance therapy of advanced\/metastatic non-squamous, non-small cell lung cancer (NSCLC)","volume":"15","author":"Cohen","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.annder.2014.11.011_bib0025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1517\/14740338.2011.553281","article-title":"Pemetrexed in advanced non-small cell lung cancer","volume":"10","author":"Gridelli","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.annder.2014.11.011_bib0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1053\/j.seminoncol.2005.11.004","article-title":"Dermatologic toxicity of chemotherapeutic agents","volume":"33","author":"Payne","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1016\/j.annder.2014.11.011_bib0035","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1200\/JCO.2004.08.163","article-title":"Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small cell lung cancer previously treated with chemotherapy","volume":"22","author":"Hanna","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.annder.2014.11.011_bib0040","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.clon.2012.01.003","article-title":"Pemetrexed-induced skin sclerosis","volume":"24","author":"Merklen-Djafri","year":"2012","journal-title":"Clin Oncol"},{"key":"10.1016\/j.annder.2014.11.011_bib0045","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jaad.2010.01.003","article-title":"Painful generalized erythematous patches: a severe and unusual cutaneous reaction to pemetrexed","volume":"65","author":"Vitiello","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2014.11.011_bib0050","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1097\/JTO.0b013e31822e722f","article-title":"Skin toxicities compromise prolonged pemetrexed treatment","volume":"6","author":"Eguia","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.annder.2014.11.011_bib0055","doi-asserted-by":"crossref","first-page":"B287","DOI":"10.1016\/j.annder.2012.10.529","article-title":"Une nouvelle toxicit\u00e9 \u00e0 ne pas m\u00e9conna\u00eetre\u00a0: la scl\u00e9rose cutan\u00e9e algique induite par le pemetrexed (Alimta\u00ae)","volume":"139S3","author":"Salle De Chou","year":"2012","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2014.11.011_bib0060","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1634\/theoncologist.10-6-363","article-title":"FDA drug approval summary: pemetrexed for injection (Alimta) for the treatment of non-small cell lung cancer","volume":"10","author":"Cohen","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.annder.2014.11.011_bib0065","first-page":"769","article-title":"Revisiting cutaneous adverse reactions to pemetrexed","volume":"2","author":"Pi\u00e9rard-Franchimont","year":"2011","journal-title":"Oncol Lett"},{"key":"10.1016\/j.annder.2014.11.011_bib0070","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0761-8425(07)91133-X","article-title":"Severe cutaneous toxicity after pemetrexed as a second line treatment for a refractory non-small cell lung cancer","volume":"24","author":"Tummino","year":"2007","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.annder.2014.11.011_bib0075","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.lungcan.2006.06.021","article-title":"Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis","volume":"54","author":"Barl\u00e9si","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.annder.2014.11.011_bib0080","first-page":"5185","article-title":"Pemetrexed-induced eyelid edema: incidence and clinical manifestations","volume":"30","author":"Schallier","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.annder.2014.11.011_bib0085","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.1365-2133.2011.10777.x","article-title":"Asteatotic eczema (\u201ceczema craquel\u00e9\u201d) with histopathological interface dermatitis: a new cutaneous reaction following pemetrexed","volume":"166","author":"Frouin","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2014.11.011_bib0090","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/07357900600629567","article-title":"Alteration of pemetrexed excretion in the presence of acute renal failure and effusions: presentation of a case and review of the litterature","volume":"24","author":"Brandes","year":"2006","journal-title":"Cancer Invest"},{"key":"10.1016\/j.annder.2014.11.011_bib0095","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/sonc.2002.37465","article-title":"Pemetrexed safety and dosing strategy","volume":"29","author":"Niyikiza","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.annder.2014.11.011_bib0100","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/annonc\/mdf115","article-title":"Phase II trial of pemetrexed disodium in chemotherapy-na\u00efve patients with advanced non-small cell lung cancer","volume":"13","author":"Clarke","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annder.2014.11.011_bib0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1468-3083.2002.00485.x","article-title":"Gemcitabine-induced erysipeloid skin lesions in a patient with malignant mesothelioma","volume":"16","author":"Kuku","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2014.11.011_bib0110","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jaad.2001.07.001","article-title":"Gemcitabine-associated scleroderma-like changes of the lower extremities","volume":"51","author":"Bessis","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2014.11.011_bib0115","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaad.2008.01.001","article-title":"Chemotherapeutic agents and the skin: an update","volume":"58","author":"Heidary","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2014.11.011_bib0120","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2133.2006.07597.x","article-title":"Taxane-induced scleroderma","volume":"156","author":"Itoh","year":"2007","journal-title":"Br J Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963814012903?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963814012903?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:02:33Z","timestamp":1758970953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963814012903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0151963814012903"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2014.11.011","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scl\u00e9rose cutan\u00e9e des deux membres inf\u00e9rieurs sous pemetrexed","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2014.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}